Drug Repositioning - GEN - Genetic Engineering and Biotechnology News

Drug Repositioning

Common HIV Treatment Improves Cognition in Down Syndrome Mice

Thalidomide

Drug Repositioning

Thalidomide Effectively Treats Damaging Blood Vessel Disorder in Humans

Dual-mechanism oral small molecule MBX-2982 acts as GPR119 agonist. [© Celso Pupo - Fotolia.com]

Drug Repositioning

Anticancer Candidate Relieves Beta Cell Overload, Reverses Diabetes in Mice

eye

Drug Repositioning

Antabuse May Help Revive Sight in People with Blinding Disorders

Woman Receiving Radiation Therapy Treatments for Head & NeckCancer

Drug Repositioning

Malaria Drug Could Combat Head and Neck Cancer Chemotherapy Resistance

Drug Repositioning

T1D Patients Benefit from Blood Pressure Drug in Two-Year Study

coronavirus

Drug Repositioning

COVID-19 Proteases Inhibited by Repurposed FDA-Approved Drugs

[iStock/FredFroese]

Drug Repositioning

Anticancer Drug Promotes Weight Loss in Obese Mice

T-Cells Work to Fight Cancer, Immunotherapy, CAR T-cell therapy, 3d renderin

On Demand Webinars

Efficacy of Polyfunctional GD3 CAR T Cells against Rare Tumors

Drug Repositioning

Antibiotic-Dietary Supplement Combo Improves Cognition in Mouse Dementia Models

Drug Repositioning

Microbiome State Affected, for Good or Ill, by Many Common Drugs

Brain Aging

Drug Repositioning

Study Suggests Erectile Dysfunction Drug May Lower Risk of Alzheimer’s

Pancreatic cancer, illustration

Drug Repositioning

Drug in RA Trials Boosts Pancreatic Cancer Vulnerability to Chemo

Tuberculosis bacteria, illustration

Drug Repositioning

Hepatitis Drug Boosts Bacterial Antibiotic Sensitivity, Dampens Resistance to Frontline TB...

Drug Repositioning

Cancer Drug “Junkyard” Screen Identifies Compound that Resets Genetic Switch to...

12 3...9 Page 1 of 9